Paclitaxel-Based Chemotherapy for Non–Small Cell Lung Cancer: Predicting the Response with 99mTc-Tetrofosmin Chest Imaging

Article Figures & Data

Download figure
Open in new tab
Download powerpoint
FIGURE 1.
In patient 1, who had good response to paclitaxel, both early and delayed anterior and posterior ^99mTc-TF chest images show significant ^99mTc-TF uptake by lung cancer (arrows).
Download figure
Open in new tab
Download powerpoint
FIGURE 2.
In patient 11, who had poor response to paclitaxel, both early and delayed anterior and posterior ^99mTc-TF chest images show no definite ^99mTc-TF uptake by lung cancer.

TABLE 1.

Patient Data

Patient no.	Sex	Age (y)	Tumor size (cm)	Stage	Cell types	^99mTc-TF chest images			Chemotherapeutic response
Patient no.	Sex	Age (y)	Tumor size (cm)	Stage	Cell types	Early T/NL	Delayed T/NL	RI (%)	Chemotherapeutic response
1	F	46	8 × 6	IV	SCC	1.60	1.40	−12.50	Good
2	M	47	5 × 6	IIIb	Adenocarcinoma	1.80	1.70	−5.56	Good
3	M	52	4 × 2	IV	Adenocarcinoma	1.40	1.30	−7.14	Good
4	F	57	6 × 4.5	IIIb	SCC	1.90	1.80	−5.26	Good
5	M	59	5 × 4.5	IV	SCC	1.30	1.30	0.00	Good
6	F	60	5 × 4	IIIb	SCC	1.30	1.20	−7.69	Good
7	F	62	5 × 3	IV	Adenocarcinoma	1.50	1.40	−6.67	Good
8	M	63	5 × 6	IV	Adenocarcinoma	2.00	1.90	−5.00	Good
9	M	66	8 × 6	IIIb	Adenocarcinoma	1.70	1.70	0.00	Good
10	M	67	4 × 4	IV	Adenocarcinoma	1.40	1.30	−7.14	Good
11	F	43	2.5 × 4	IV	Adenocarcinoma	1.00	1.00	0.00	Poor
12	M	45	3 × 5	IV	SCC	1.20	1.10	−8.33	Poor
13	F	48	4.5 × 5	IV	Adenocarcinoma	1.00	1.00	0.00	Poor
14	F	54	3 × 3	IV	SCC	1.20	1.10	−8.33	Poor
15	M	58	7 × 5	IV	Adenocarcinoma	1.10	1.00	−9.09	Poor
16	M	61	9 × 7	IV	Adenocarcinoma	1.10	1.00	−9.09	Poor
17	M	65	3.5 × 3	IV	Adenocarcinoma	1.20	1.10	−8.33	Poor
18	M	65	3.5 × 3	IV	Adenocarcinoma	1.00	1.00	0.00	Poor
19	M	69	3 × 3	IIIb	SCC	1.00	1.00	0.00	Poor
20	M	70	6 × 6	IIIb	SCC	1.10	1.00	−9.09	Poor